Financhill
Back

Sanara MedTech Quote, Financials, Valuation and Earnings

Sell
46

SMTI
Sanara MedTech

Last Price:
30.47
Seasonality Move:
25.33%

7 Day Trial

ALL ACCESS PASS

$ 7

Sanara MedTech Price Quote

$30.47
-0.04 (-3.88%)
(Updated: May 18, 2024 at 4:41 AM ET)

Sanara MedTech Key Stats

Sell
46
Sanara MedTech (SMTI) is a Sell

Day range:
$30.00 - $32.35
52-week range:
$26.06 - $46.40
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
3.74
P/B ratio:
6.08%

Volume:
17.5K
Avg. volume:
15.3K
1-year change:
-19.84%
Market cap:
$263.2M
Revenue:
$65M
EPS:
$-0.59

How Much Does Sanara MedTech Make?

Is Sanara MedTech Growing As A Company?

  • What Is Sanara MedTech's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.19%
  • What Is Sanara MedTech's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Sanara MedTech Stock Price Performance

  • Did Sanara MedTech Stock Go Up Last Month?
    Sanara MedTech share price went down by -3.45% last month
  • Did SMTI's Share Price Rise Over The Last Year?
    SMTI share price fell by -19.84% over the past 1 year

What Is Sanara MedTech 52-Week High & Low?

Sanara MedTech Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Sanara MedTech?

  • How Much Debt Does Sanara MedTech Have?
    Total long term debt quarterly is $9.7M
  • How Much Cash Does Sanara MedTech Have?
    Cash and short term investments quarterly total is $2.8M
  • What Is Sanara MedTech’s Book Value Per Share?
    Book value per share is 5.02

Is Sanara MedTech Cash Flow Positive?

  • What Is SMTI Cash Flow From Operations?
    Cash flow from operations (TTM) is -$3.1M
  • What Is Sanara MedTech’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $8.9M
  • What Is Sanara MedTech’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$10.2M

Sanara MedTech Return On Invested Capital

  • Is Management Doing A Good Job?
    SMTI return on invested capital is -10.05%
  • What Is Sanara MedTech Return On Assets?
    ROA measures how assets are converting to revenues and is -7.22%
  • What Is SMTI Return On Equity?
    ROE is a measure of profitability and is -11.42%

Sanara MedTech Earnings Date & Stock Price

Sanara MedTech Competitors

  • Who Are Sanara MedTech's Competitors?
    Below is a list of companies who compete with Sanara MedTech or are related in some way:
    • AptarGroup Inc (ATR)
    • Perspective Therapeutics Inc (CATX)
    • Daxor Corp (DXR)
    • Precision Optics Corp Inc (POCI)
    • Warby Parker Inc (WRBY)

Sanara MedTech Dividend Yield

Data Unavailable

Sanara MedTech Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 19.42% 0.2%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 44.00
Upside from Last Price: 44.22%

Major Shareholders

  • How many SMTI shares are owned by institutional investors?
    1.2M SMTI shares are owned by institutional investors
  • How many SMTI shares are owned by insiders?
    0 SMTI shares are owned by insiders